Correction to Abbott Labs Deals Story
31 July 2015 - 3:28AM
Dow Jones News
Abbott Laboratories agreed to acquire the remaining stake in
privately held Tendyne Holdings Inc. that it doesn't already own
for $225 million upfront, resulting in a total transaction value of
$250 million, plus potential milestone payments. "Abbott Labs
Reaches Deals for Transcatheter Mitral-Valve Developers" published
at 11:54 a.m. EDT incorrectly described the terms of the deal in
the third paragraph.
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
Abbott Laboratories (NYSE:ABT)
Historical Stock Chart
From Apr 2024 to May 2024
Abbott Laboratories (NYSE:ABT)
Historical Stock Chart
From May 2023 to May 2024